Navigation Links
ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results
Date:4/3/2013

SAN DIEGO, April 3, 2013 /PRNewswire/ -- RESMED INC. (NYSE: RMD) announced today that on Thursday, April 25, 2013, it will release its results for the third quarter and nine months of fiscal year 2013, ended March 31, 2013. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a conference call and webcast to review its results, market trends, and future outlook.

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

The conference call is scheduled to begin at 1:30 p.m. US Pacific Time and will be webcast on ResMed's website at http://investor.resmed.com.  Please go to this section of the website 5-10 minutes before the call and click on the icon for the "Q3 2013 results webcast." The online archive of the broadcast will be available approximately 30 minutes after the live call and will continue to be available for two weeks.

International conference call times will be:9:30 p.m.

London6:30 a.m.

Sydney, Australia (April 26, 2013)TO PARTICIPATE in the conference call, please call one of the numbers below at least 10 minutes before the call begins and identify yourself to the operator:US:

847-585-4405 Outside US:

+1 847-585-4405Conference Name:

Q3 2013 ResMed Inc. Results Conference Call  Participant Passcode:

34598681The replay of the conference call will be available approximately 30 minutes after the call and will be accessible for two weeks at:US:

630- 652-3042Outside US:

+1 630-652-3042Passcode:

34598681ResMed is a global leader in the development, manufacturing, and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. Further information can be obtained by contacting Constance Bienfait at ResMed Inc. at +1 (858) 836-5971, or by visiting the company's website at www.resmed.com.


'/>"/>
SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ResMed Takes Action to Enforce Patents
2. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
3. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2012
4. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
5. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
6. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
7. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
8. ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
9. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
10. Akorn, Inc. Announces First Quarter 2013 Earnings Release And Conference Call Information
11. Dynamic Healthcare Services Announces David Erb as Director of Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... New York , February 20, 2017 ... regularized absorption of calcium and phosphorous minerals in one,s ... of vitamin D ingredients in maintaining a healthy composition ... medicines containing vitamin D ingredients is growing in the ... advantage of consuming vitamin D ingredients for treatment of ...
(Date:2/19/2017)... 19, 2017  nThrive™, an independent Patient-to-Payment? solutions ... thought leadership at the 2017 HIMSS Conference. The ... award from KLAS. nThrive will host ... how market trends shape the holistic, integrated revenue ... comprehensive Patient Access solution. The panel will reveal ...
(Date:2/18/2017)... PORT WASHINGTON, N.Y. , Feb. 17, 2017 ... law firm dedicated to protecting the rights of ... device problems have prompted regulators to call for ... events in 1990. Safety concerns involving ... and Drug Administration (FDA) to investigate how hospitals ...
Breaking Medicine Technology:
(Date:2/20/2017)... ... February 20, 2017 , ... ... full range of emergency dental care at his office, Antoine Dental Center. Emergency ... experience dental emergencies, they are at risk for serious complications and often experience ...
(Date:2/19/2017)... ... February 19, 2017 , ... The Citadel’s new Swain Department ... being led by Amelia Joseph, Ph.D. Joseph was engaged by the college as a ... department in early 2016. After a nation-wide search, she was selected to head the ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... Devicemakers , Sponsored by Axendia, **FDAnews Free Webinar**, March 1, 2017 — ... looking to reduce their regulatory burden? Pay dividends in enhanced and predictable ...
(Date:2/18/2017)... ... February 18, 2017 , ... ProParagraph Fashion ... Film Studios ’ ProParagraph Fashion Volume 2 for all multi-line FCPX project needs. ... Users can pick and choose from hand-crafted trend-setting designs with smooth animations that ...
(Date:2/17/2017)... ... February 17, 2017 , ... Wells Pharmacy ... electronic prescribing of controlled and non-controlled substances plus the ability to manage orders ... the United States now accept electronic prescriptions, according to the Office of the ...
Breaking Medicine News(10 mins):